Sugammadex
- Product NDC
- 25021-619
- Requested package NDC
- 25021-619-05
- 11-digit product format
- 250210619
- Labeler code
- 25021
- Product ID
- 25021-619_56db464b-e9db-4a9b-bb38-b5ddfa0fc6b8
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Sugammadex Sodium
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Sagent Pharmaceuticals
- Application
- ANDA215575
- Marketing category
- ANDA
- Marketing start
- 2026-07-01
- Substance
- SUGAMMADEX SODIUM
- Active strength
- 100 mg/mL
- Pharmacologic classes
- gamma-Cyclodextrins [CS]
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sugammadex | SUGAMMADEX SODIUM | Sagent Pharmaceuticals | 5b25f16e-726a-4464-88da-b188c2f4e038 | 2026-06-16 | Warnings, Adverse reactions | 215575 ANDA215575 25021-619-05 25021-619 25021061905 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Sugammadex
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| SUGAMMADEX SODIUM | 100 mg/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| ERJ6X2MXV7 | Internal UNII lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 5b25f16e-726a-4464-88da-b188c2f4e038 | Available on FDA.report |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Status |
|---|---|---|---|---|---|---|
| 25021-619-05 | 25021061905 | 10 VIAL in 1 CARTON (25021-619-05) / 5 mL in 1 VIAL | 10 vial | 2026-07-01 | 0 | Current |